The Latest Breaking News from Wells Fargo

Wells Fargo's (NYSE:WFC) short percent of float has fallen 21.57% since its last report. The company recently reported that it has 30.37 million shares sold short, which is 0.8% of all regular shares that are available for trading.

Everything you need to know for the second round of the Wells Fargo.

Wells Fargo has decided to maintain its Overweight rating of Morphic Holding (NASDAQ:MORF) and lower its price target from $81.00 to $79.00. Shares of Morphic Holding are trading down 3.76% over the last 24 hours, at $33.25 per share.

On today's episode of "Professional Golfers, They're Just Like Us!" we welcome Marc Leishman to the mix.

Upgrades

Analyst views remain mixed post Skyworks Solutions, Inc's (NASDAQ: SWKS) 

"No one owns the game of golf. Golf is for everybody."

Wells Fargo is reiterating its Overweight rating after Kezar Life Sciences Inc's (NASDAQ:KZR) zeto (KZR-616) Phase 2 trial in dermatomyositis/polymyositis failed to top placebo on the trial's primary endpoint of mean total improvement score (TIS). The analysts had viewed the program as a free call option for shares at these levels and argued that there…

Penumbra Inc (NYSE:PEN) reported Q1 sales that beat Street expectations, driven by Vascular upside, and reiterated its 2022 revenue guidance.  Wells Fargo lowered the price target to $265 from 321, which is equivalent to a 52.2% upside.  At 9.5x (down from 12x as peer group valuation has been compressed) with a 2023 sales estimate of…